1. Esmaeili Y, Yarjanli Z, Pakniya F, et al. Targeting autophagy, oxidative stress, and ER stress for neurodegenerative disease treatment. Journal of Controlled Release. 345, 147–175 (2022).
2. Johri A, Beal MF. Mitochondrial dysfunction in neurodegenerative diseases. J Pharmacol Exp Ther. 342(3), 619–630 (2012).
3. Mattson MR. Calcium and neurodegeneration. Aging Cell. 6(3), 337–350 (2007).
4. Verkhratsky A, Toescu EC. Endoplasmic reticulum Ca(2+) homeostasis and neuronal death. J Cell Mol Med. 7(4), 351–361 (2003).
5. Schrank S, Barrington N, Stutzmann GE. Calcium-Handling Defects and Neurodegenerative Disease. Cold Spring Harb Perspect Biol. 12(7), 1–25 (2020).
* Discusses that calcium signaling is critical to neuronal function as it is the upstream underlying basis for the pathogenesis of ND.
6. Sprenkle NT, Sims SG, Sánchez CL, Meares GP. Endoplasmic reticulum stress and inflammation in the central nervous system. Mol Neurodegener. 12(1), 1–18 (2017).
* Deliberated the mechanisms by which stress-induced inflammation contributes to the pathogenesis and progression of neurodegenerative diseases.
7. Walter P, Ron D. The unfolded protein response: From stress pathway to homeostatic regulation. Science. 334(6059), 1082–1086 (2011).
8. Lindholm D, Wootz H, Korhonen L. ER stress and neurodegenerative diseases. Cell Death Differ. 13(3), 385–392 (2006).
9. Tanna T, Sachan V. Mesenchymal Stem Cells: Potential in Treatment of Neurodegenerative Diseases. Curr Stem Cell Res Ther. 9(6), 513–521 (2014).
10. Sudjarwo S, Sudjarwo G, Koerniasari K. Protective effect of curcumin on lead acetate-induced testicular toxicity in Wistar rats. Res Pharm Sci. 12(5), 381 (2017).
11. Yao P, Zhou L, Zhu L, Zhou B, Yu Q. Mesenchymal Stem Cells: A Potential Therapeutic Strategy for Neurodegenerative Diseases. Eur Neurol. 83(3), 235–241 (2020).
12. Wobst HJ, Mack KL, Brown DG, Brandon NJ, Shorter J. The clinical trial landscape in amyotrophic lateral sclerosis—Past, present, and future. Med Res Rev. 40(4), 1352–1384 (2020).
13. Zriek F, di Battista JA, Alaaeddine N. Mesenchymal Stromal Cell Secretome: Immunomodulation, Tissue Repair and Effects on Neurodegenerative Conditions. Curr Stem Cell Res Ther. 16(6), 656–669 (2021).
14. Kean TJ, Lin P, Caplan AI, Dennis JE. MSCs: Delivery routes and engraftment, cell-targeting strategies, and immune modulation. Stem Cells Int. 2013, 732–742 (2013).
15. Lee S, Choi E, Cha MJ, Hwang KC. Cell adhesion and long-term survival of transplanted mesenchymal stem cells: A prerequisite for cell therapy. Oxid Med Cell Longev. 2015, 632902 (2015).
16. Wu X, Jiang J, Gu Z, Zhang J, Chen Y, Liu X. Mesenchymal stromal cell therapies: Immunomodulatory properties and clinical progress. Stem Cell Res Ther. 11(1), 345 (2020).
17. Teli P, Kale V, Vaidya A. Extracellular vesicles isolated from mesenchymal stromal cells primed with neurotrophic factors and signaling modifiers as potential therapeutics for neurodegenerative diseases, (2021).
** Discusses priming as a strategy for harnessing the therapeutic potential of the MSCs for promoting neuroregeneration.
18. Pendse S, Kale V, Vaidya A. Extracellular Vesicles Isolated from Mesenchymal Stromal Cells Primed with Hypoxia: Novel Strategy in Regenerative Medicine. Curr Stem Cell Res Ther 16(3) (2021).
19. Kale VP. Application of ‘primed’ Mesenchymal Stromal Cells in Hematopoietic Stem Cell Transplantation: Current Status and Future Prospects, (2019).
20. Noronha Nc NDC, Mizukami A, Caliári-Oliveira C, et al. Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies. Stem Cell Res Ther. 10(1), 131 (2019).
21. Jalnapurkar S, Moirangthem RD, Singh S, Limaye L, Kale V. Microvesicles Secreted by Nitric Oxide-Primed Mesenchymal Stromal Cells Boost the Engraftment Potential of Hematopoietic Stem Cells. Stem Cells (2019).
22. Budgude P, Kale V, Vaidya A. Pharmacological Inhibition of p38 MAPK Rejuvenates Bone Marrow Derived-Mesenchymal Stromal Cells and Boosts their Hematopoietic Stem Cell-Supportive Ability. Stem Cell Rev Rep 17(6) (2021).
23. Moirangthem RD, Singh S, Adsul A, Jalnapurkar S, Limaye L, Kale VP. Hypoxic niche-mediated regeneration of hematopoiesis in the engraftment window is dominantly affected by oxygen tension in the milieu. Stem Cells Dev 24(20) (2015).
24. Pendse S, Kale V, Vaidya A. The Intercellular Communication Between Mesenchymal Stromal Cells and Hematopoietic Stem Cells Critically Depends on NF-κB Signalling in the Mesenchymal Stromal Cells. Stem Cell Rev Rep (2022).
25. Teli P, Kale V, Vaidya A. Mesenchymal stromal cells-derived secretome protects Neuro-2a cells from oxidative stress-induced loss of neurogenesis. Exp Neurol 354 (2022).
** Demonstrates that the secretome derived from MSCs exerts a neuroprotective effect on oxidative stress-induced loss of neurogenesis.
26. Lawson B, Brewer JW, Hendershot LM. Geldanamycin, an hsp90/GRP94-binding drug, induces increased transcription of endoplasmic reticulum (ER) chaperones via the ER stress pathway. J Cell Physiol. 174(2), 107–8 (1998).
27. Talwadekar M, Fernandes S, Kale V, Limaye L. Valproic acid enhances the neural differentiation of human placenta derived-mesenchymal stem cells in vitro. J Tissue Eng Regen Med 11(11), 3111–3123 (2017).
** Shows that MSCs primed with neurotrophic factors differentiate into neuronal-like cells, thereby underscoring the importance of priming MSCs to enhance their propensity to differentiate into neuronal-like cells.
28. Shihan MH, Novo SG, le Marchand SJ, Wang Y, Duncan MK. A simple method for quantitating confocal fluorescent images. Biochem Biophys Rep. 25, 100916 (2021).
29. Duangjan C, Rangsinth P, Zhang S, Wink M, Tencomnao T. Anacardium Occidentale L. Leaf Extracts Protect Against Glutamate/H2O2-Induced Oxidative Toxicity and Induce Neurite Outgrowth: The Involvement of SIRT1/Nrf2 Signaling Pathway and Teneurin 4 Transmembrane Protein. Front Pharmacol. 12, 627738 (2021).
30. Kang S, Chen X, Gong S, et al. Characteristic analyses of a neural differentiation model from iPSC-derived neuron according to morphology, physiology, and global gene expression pattern. Sci Rep. 7(1), 12233 (2017).
31. Hosoi T, Hyoda K, Okuma Y, Nomura Y, Ozawa K. Geldanamycin induces CHOP expression through a 4-(2-aminoethyl)- benzenesulfonyl fluoride-responsive serine protease. Cell Res. 17(2), 184–6 (2007).
32. Kawada K, Iekumo T, Saito R, et al. Aberrant neuronal differentiation and inhibition of dendrite outgrowth resulting from endoplasmic reticulum stress. J Neurosci Res. 92(9), 1122–1133 (2014).
** Shows that ER stress induction in neuronal cells inhibits neuronal differentiation and neurite outgrowth formation, suggesting that ER stress induction leads to loss of neurogenesis.
33. Hu H, Tian M, Ding C, Yu S. The C/EBP homologous protein (CHOP) transcription factor functions in endoplasmic reticulum stress-induced apoptosis and microbial infection. Front Immunol. 9, 3083 (2019).
34. Chaudhari N, Talwar P, Parimisetty A, d’Hellencourt CL, Ravanan P. A molecular web: Endoplasmic reticulum stress, inflammation, and oxidative stress. Front Cell Neurosci. 8, 213 (2014).
35. Kitamura M. Control of NF-κB and inflammation by the unfolded protein response. Int Rev Immunol. 30(1), 4–15 (2011).
36. Fribley A, Zhang K, Kaufman RJ. Regulation of apoptosis by the unfolded protein response. Methods Mol Biol. 559, 191–204 (2009).
37. Liu L, Arun A, Ellis L, Peritore C, Donmez G. SIRT2 enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced nigrostriatal damage via apoptotic pathway. Front Aging Neurosci. 6, 184 (2014).
38. Outeiro TF, Kontopoulos E, Altmann SM, et al. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson’s disease. Science. 317(5837), 516–519 (2007).
39. Gao HM, Hong JS. Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends Immunol. 29(8), 357–65 (2008).
40. Lin WC, Chuang YC, Chang YS, et al. Endoplasmic reticulum stress stimulates p53 expression through NF-κB activation. PLoS One. 7(7), e39120 (2012).
41. Lee KM, Kang BS, Lee HL, et al. Spinal NF-kB activation induces COX-2 upregulation and contributes to inflammatory pain hypersensitivity. European Journal of Neuroscience. 19(12), 3375–81 (2004).
42. Darling NJ, Cook SJ. The role of MAPK signalling pathways in the response to endoplasmic reticulum stress. Biochim Biophys Acta Mol Cell Res. 1843(10), 2150–63 (2014).
43. Raza SS, Seth P, Khan MA. ‘Primed’ Mesenchymal Stem Cells: a Potential Novel Therapeutic for COVID19 Patients. Stem Cell Rev Rep. 17(1), 153–162 (2021).
44. Outeiro TF, Kontopoulos E, Altmann SM, et al. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson’s disease. Science. 317(5837), 516–519 (2007).
45. Tabas I, Ron D. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat Cell Biol. 13(3), 184–90 (2011).
46. Wright AL, Zinn R, Hohensinn B, et al. Neuroinflammation and Neuronal Loss Precede Aβ Plaque Deposition in the hAPP-J20 Mouse Model of Alzheimer’s Disease. PLoS One. 8(4), e59586 (2013).
47. Cordeiro MF, Guo L, Coxon KM, et al. Imaging multiple phases of neurodegeneration: A novel approach to assessing cell death in vivo. Cell Death Dis. 1(1), e3 (2010).
48. Chong WC, Shastri MD, Eri R. Molecular Sciences Endoplasmic Reticulum Stress and Oxidative Stress: A Vicious Nexus Implicated in Bowel Disease Pathophysiology. Int J Mol Sci. 18(4), 771 (2017).
49. Malhotra JD, Kaufman RJ. Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? Antioxid Redox Signal. 9(12), 2277–2293 (2007).
50. Lindholm D, Korhonen L, Eriksson O, Kõks S. Recent insights into the role of unfolded protein response in ER stress in health and disease. Front Cell Dev Bio. l5, 48 (2017).
51. Matus S, Glimcher LH, Hetz C. Protein folding stress in neurodegenerative diseases: A glimpse into the ER. Curr Opin Cell Bio. l23(2), 239–52 (2011).
52. Tam AB, Mercado EL, Hoffmann A, Niwa M. ER Stress Activates NF-κB by Integrating Functions of Basal IKK Activity, IRE1 and PERK. PLoS One. 7(10), e45078 (2012).
53. Bartels A, Leenders K. Cyclooxygenase and neuroinflammation in Parkinson’s disease neurodegeneration. Curr Neuropharmacol. 8(1), 62–68 (2010).
54. Kaltschmidt B, Linker RA, Deng J, Kaltschmidt C. Cyclooxygenase-2 is a neuronal target gene of NF-κb. BMC Mol Biol. 3, 16 (2002).
55. Vukicévić V, Qin N, Balyura M, et al. Valproic acid enhances neuronal differentiation of sympathoadrenal progenitor cells. Mol Psychiatry. 20(8), 941–50 (2015).
56. Kim H, Zahir T, Tator CH, Shoichet MS. Effects of dibutyryl cyclic-AMP on survival and neuronal differentiation of neural stem/progenitor cells transplanted into spinal cord injured rats. PLoS One. 6(6), e21744 (2011).
57. Delcroix GJR, Curtis KM, Schiller PC, Montero-Menei CN. EGF and bFGF pre-treatment enhances neural specification and the response to neuronal commitment of MIAMI cells. Differentiation. 80(4–5), 213–27 (2010).
58. Yu IT, Park JY, Kim SH, Lee J sik, Kim YS, Son H. Valproic acid promotes neuronal differentiation by induction of proneural factors in association with H4 acetylation. Neuropharmacology. 56(2), 473–80 (2009).
59. Zahir T, Chen YF, MacDonald JF, Leipzig N, Tator CH, Shoichet MS. Neural stem/progenitor cells differentiate in vitro to neurons by the combined action of dibutyryl cAMP and interferon-γ. Stem Cells Dev. 18(10), 1423–32 (2009).
60. Munoz-Perez E, Gonzalez-Pujana A, Igartua M, Santos-Vizcaino E, Hernandez RM. Mesenchymal stromal cell secretome for the treatment of immune-mediated inflammatory diseases: Latest trends in isolation, content optimization and delivery avenues. Pharmaceutics. 13(11), 1802 (2021).
61. Pinho AG, Cibrão JR, Silva NA, Monteiro S, Salgado AJ. Cell secretome: Basic insights and therapeutic opportunities for CNS disorders. Pharmaceuticals. 13(2), 31 (2020).
62. Varderidou-Minasian S, Lorenowicz MJ. Mesenchymal stromal/stem cell-derived extracellular vesicles in tissue repair: Challenges and opportunities. Theranostics. 10(13), 5979–5997 (2020).
63. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 9(6), 654–9 (2007).
64. Kulkarni R, Bajaj M, Ghode S, Jalnapurkar S, Limaye L, Kale VP. Intercellular Transfer of Microvesicles from Young Mesenchymal Stromal Cells Rejuvenates Aged Murine Hematopoietic Stem Cells. Stem Cells (2018).
65. Doyle L, Wang M. Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis. Cells. 8(7), 727 (2019).
66. Saint-Pol J, Gosselet F, Duban-Deweer S, Pottiez G, Karamanos Y. Targeting and Crossing the Blood-Brain Barrier with Extracellular Vesicles. Cells. 9(4), 851 (2020).
67. Vaquero J, Zurita M, Rico MA, et al. Repeated subarachnoid administrations of autologous mesenchymal stromal cells supported in autologous plasma improve quality of life in patients suffering incomplete spinal cord injury. Cytotherapy. 19(3), 349–359 (2017).
68. Zhao Y, Tang F, Xiao Z, et al. Clinical study of neuroregen scaffold combined with human mesenchymal stem cells for the repair of chronic complete spinal cord injury. Cell Transplant. 26(5), 891–900 (2017).
69. Dahbour S, Jamali F, Alhattab D, et al. Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and efficacy. CNS Neurosci Ther. 23(11), 866–874 (2017).
70. Gowen A, Shahjin F, Chand S, Odegaard KE, Yelamanchili S v. Mesenchymal Stem Cell-Derived Extracellular Vesicles: Challenges in Clinical Applications. Front Cell Dev Biol. 8(March), 1–8 (2020).
71. Linares GR, Chiu CT, Scheuing L, et al. Preconditioning mesenchymal stem cells with the mood stabilizers lithium and valproic acid enhances therapeutic efficacy in a mouse model of Huntington’s disease. Exp Neurol. 281, 81–92 (2016).
72. Kim HW, Lee HS, Kang JM, et al. Dual Effects of Human Placenta-Derived Neural Cells on Neuroprotection and the Inhibition of Neuroinflammation in a Rodent Model of Parkinson’s Disease. Cell Transplant. 27(5), 814 (2018).
73. Somoza R, Juri C, Baes M, Wyneken U, Rubio FJ. Intranigral transplantation of epigenetically induced BDNF-secreting human mesenchymal stem cells: implications for cell-based therapies in Parkinson’s disease. Biol Blood Marrow Transplant. 16(11), 1530–1540 (2010).
74. Nouri F, Salehinejad P, Nematollahi-mahani SN, Kamarul T, Zarrindast MR, Sharifi AM. Deferoxamine Preconditioning of Neural-Like Cells Derived from Human Wharton’s Jelly Mesenchymal Stem Cells as a Strategy to Promote Their Tolerance and Therapeutic Potential: An In Vitro Study. Cell Mol Neurobiol. 36(5), 689–700 (2016).